Severe hypercalcemia following denosumab treatment in a juvenile patient

Osteosclerosis induced by denosumab

(2015) Eisuke Kobayashi et al.   LANCET

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

(2015) Nathan Gossai et al.   PEDIATRIC BLOOD & CANCER

Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease

(2013) Corinna Grasemann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

(2013) Sant Chawla et al.   LANCET ONCOLOGY

Denosumab treatment for fibrous dysplasia

(2012) Alison M Boyce et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective

(2012) Steven Boonen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase

(2012) D.-C. Fischer et al.   ANNALS OF CLINICAL BIOCHEMISTRY